Human Immunodeficiency Virus Protease Inhibitors Interact with ATP Binding Cassette Transporter 4 / Multidrug Resistance Protein 4 : A Basis for Unanticipated Enhanced Cytotoxicity s

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Computational Modeling to Accelerate the Identification of Substrates and Inhibitors for Transporters That Affect Drug Disposition

  2012cited by this paper
• Multi-drug Resistance Protein 4 (MRP4)-mediated Regulation of Fibroblast Cell Migration Reflects a Dichotomous Role of Intracellular Cyclic Nucleotides*

  2012cited by this paper
• ABC transporters and their role in nucleoside and nucleotide drug resistance.

  2012cited by this paper
• Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir.

  2012cited by this paper
• Molecular Determinants of Ligand Selectivity for the Human Multidrug and Toxin Extruder Proteins MATE1 and MATE2-K

  2012cited by this paper
• The rising challenge of non-AIDS-defining cancers in HIV-infected patients.

  2012influential reference
• Deoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity.

  2011cited by this paper
• Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?

  2011cited by this paper
• Use of antineoplastic agents in patients with cancer who have HIV/AIDS.

  2011cited by this paper
• Drug Discovery Using Chemical Systems Biology: Weak Inhibition of Multiple Kinases May Contribute to the Anti-Cancer Effect of Nelfinavir

  2011influential reference
• Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines.

  2010cited by this paper
• Troubleshooting computational methods in drug discovery.

  2010cited by this paper
• The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters.

  2010cited by this paper
• Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery.

  2009cited by this paper
• HMDB: a knowledgebase for the human metabolome

  2008cited by this paper
• The Effect of Lopinavir/Ritonavir on the Renal Clearance of Tenofovir in HIV‐infected Patients

  2008cited by this paper
• Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides

  2008cited by this paper
• Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules.

  2008influential reference
• Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo

  2007cited by this paper
• Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution.

  2007influential reference
• Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir

  2007cited by this paper
• Human Pregnane X Receptor Antagonists and Agonists Define Molecular Requirements for Different Binding Sites

  2007cited by this paper
• Treatment of acute lymphoblastic leukemia.

  2006cited by this paper
• Mechanism of Active Renal Tubular Efflux of Tenofovir

  2006cited by this paper
• Comparative Pharmacophore Modeling of Organic Anion Transporting Polypeptides: A Meta-Analysis of Rat Oatp1a1 and Human OATP1B1

  2005cited by this paper
• Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites.

  2005cited by this paper
• In Vitro and Pharmacophore-Based Discovery of Novel hPEPT1 Inhibitors

  2005influential reference
• HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo.

  2005cited by this paper
• Modulatory effects of plant phenols on human multidrug‐resistance proteins 1, 4 and 5 (ABCC1, 4 and 5)

  2005cited by this paper
• HIV‐1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling

  2005cited by this paper
• HIV Protease Inhibitors Are Inhibitors but Not Substrates of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)

  2004cited by this paper
• Multidrug Resistance Protein 4 (ABCC4)-mediated ATP Hydrolysis

  2004influential reference
• Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy

  2004cited by this paper
• The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs

  2003cited by this paper
• Tenofovir disoproxil fumarate

  2003cited by this paper
• Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.

  2003cited by this paper
• Expression of MRP4 Confers Resistance to Ganciclovir and Compromises Bystander Cell Killing*

  2002cited by this paper
• Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system.

  2002influential reference
• Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates.

  2002influential reference
• Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.

  2002influential reference
• Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein.

  2000cited by this paper
• KEGG: Kyoto Encyclopedia of Genes and Genomes

  2000influential reference
• MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs

  1999cited by this paper
• Antitumor potential of acyclic nucleoside phosphonates.

  1999cited by this paper
• Enhanced 9-(2-phosphonylmethoxyethyl)adenine secretion by a specific, indomethacin-sensitive efflux pump in a mutant 9-(2-phosphonylmethoxyethyl)adenine-resistant human erythroleukemia K562 cell line.

  1998cited by this paper
• Drug-stimulatable ATPase activity in crude membranes of human MDR1-transfected mammalian cells.

  1998cited by this paper
• A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HIV)-1 protease, to treat HIV infection.

  1998cited by this paper
• Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.

  1997cited by this paper
• Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up.

  1995cited by this paper

• No citing papers are available for this paper.